Table I.

Characteristic of the 31 patients with epithelial ovarian carcinoma.

Case no.	Tumor	FHOC	Age, years	CA-125, U/mla	EOC Histologyb	Grade	FIGO stage	Residual disease, cmc	OS time, months
1	2	Negative	63	>600	Serous	G3	IIIC	>5	12.3
2	21	Negative	58	>600	Serous	G1	IIIC	>5	10.1
3	23	Negative	42	1161	Undifferentiated	G3	IIIC	<1	106.7
4	32	Negative	74	4207	Serous	G3	IIIC	1–5	6.9
5	37	Positive	55	399	Serous	G3	IIIC	1–5	33.2
6	40	Negative	48	No data	Serous	G1	IIIC	<1	7.2
7	49	Negative	41	No data	Serous	G2	IIIC	<1	63.0
8	56	Positive	46	654	Serous	G3	IIIC	<1	104.3
9	58	Negative	77	No data	Serous	G2	IIIC	<1	0.3
10	63	Negative	60	14	Serous	G1	IC	0	32.5
11	74	Positive	45	599	Serous	G2	IV	>5	19.6
12	93	Negative	75	319	Serous	G3	IIIC	1–5	19.9
13	102	Negative	32	326	Clear cell	G2	IIC	0	130.9
14	118	Negative	79	7368	Serous	G2	IIIC	>5	35.0
15	127	Negative	47	198	Undifferentiated	G3	IIIB	<1	100.4
16	135	Negative	55	>600	Serous	G1	IIIC	1–5	16.9
17	137	Negative	63	No data	Serous	G1	IIIC	<1	17.8
18	150	Negative	56	403	Serous	G3	IIIC	<1	0.2
19	153	Positive	48	1089	Serous	G3	IIIC	<1	87.3
20	157	Negative	37	>600	Serous	G2	IIIC	<1	21.5
21	165	Negative	59	10	Serous	G2	IIIC	>5	14.6
22	170	Positive	78	No data	Serous	G1	IIIC	>5	18.0
23	172	Negative	54	1001	Serous	G2	IIIC	1–5	94.3
24	182	Negative	73	563	Undifferentiated	G3	IV	<1	26.6
25	200	Negative	73	4851	Serous	G3	IV	<1	7.0
26	211	Positive	82	802	Serous	G2	IIIA	<1	41.7
27	218	Negative	88	No data	Serous	G1	IV	<1	No FU
28	219	Negative	54	311	Undifferentiated	G3	IIIC	1–5	84.5
29	257	Negative	62	300	Serous	G2	IIIC	>5	25.8
30	766	Positive	46	156	Endometrioid	G3	IIB	0	43.3
31	792	Negative	36	136	Serous	G1	IIIB	0	106.9

^aCA125 normal range, 4–41 U/ml (29).

^b(15).

^cResidual disease, R, is presented as the diameter of the largest tumor left after primary surgery; FHOC, familiar history of ovarian cancer. OS, overall survival; NA, not applicable; CA-125, cancer antigen 125; FIGO, International Federation of Gynecology and Obstetrics; FU, follow-up.